$48.44
-4.86-9.12%
Last update: Dec 16, 9:30 AM
Comments
Loading...
Nektar Therapeutics Insider Trading Activity
NKTRNASDAQ
Nektar Therapeutics Insider Trading Activity | NASDAQ:NKTR | Benzinga
Track the latest Nektar Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Nektar Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Nektar Therapeutics Insiders Doing?
At Nektar Therapeutics, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of - shares worth -, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Nektar Therapeutics
Shares Outstanding
20.342M
Insider Shares Owned
3.617M
Insider Percentage Owned
17.8%
Institutional Shares Held
3.617M
Institutional Percentage Held
27.6%
| Nov 25, 2025 | Jonathan Zalevsky | CHIEF R&D OFFICER | 1.51K | $54.28 | -$62.80K | GRANT | 8.64% | 18.97K | Nov 21 - Nov 25 | View |
| Nov 25, 2025 | Mark A. Wilson | CHIEF LEGAL OFFICER | 1.27K | $54.28 | -$34.20K | GRANT | 6.27% | 21.59K | Nov 21 - Nov 25 | View |
| Nov 25, 2025 | HOWARD ROBIN | PRESIDENT & CEO | 4.90K | $54.28 | -$119.80K | GRANT | 9.93% | 54.27K | Nov 21 - Nov 25 | View |
| Sep 11, 2025 | HOWARD ROBIN | PRESIDENT & CEO | -6.67K | $46.69 | -$311.21K | SELL | -11.90% | 49.37K | Sep 09 | View |
| Sep 08, 2025 | Jonathan Zalevsky | CHIEF R&D OFFICER | -1.72K | $33.52 | -$57.69K | SELL | -8.97% | 17.46K | Sep 04 | View |
| Sep 08, 2025 | HOWARD ROBIN | PRESIDENT & CEO | -11.83K | $36.42 | -$430.96K | SELL | -17.43% | 56.04K | Sep 04 - Sep 05 | View |
| Sep 04, 2025 | Jonathan Zalevsky | CHIEF R&D OFFICER | -485.00 | $30.10 | -$14.60K | SELL | -2.47% | 19.18K | Sep 02 | View |
| Sep 04, 2025 | HOWARD ROBIN | PRESIDENT & CEO | -1.50K | $30.16 | -$45.24K | SELL | -2.16% | 67.87K | Sep 02 | View |
| Aug 21, 2025 | Jonathan Zalevsky | CHIEF R&D OFFICER | -725.00 | $26.59 | -$19.28K | SELL | -3.56% | 19.67K | Aug 19 | View |
| Aug 21, 2025 | Mark A. Wilson | CHIEF LEGAL OFFICER | -676.00 | $26.59 | -$17.97K | SELL | -3.22% | 20.31K | Aug 19 | View |
| Aug 21, 2025 | HOWARD ROBIN | PRESIDENT & CEO | -1.57K | $26.59 | -$41.83K | SELL | -2.22% | 69.37K | Aug 19 | View |
| May 21, 2025 | Jonathan Zalevsky | CHIEF R&D OFFICER | -10.71K | $0.67 | -$7.18K | SELL | -3.38% | 305.89K | May 19 | View |
| May 21, 2025 | Mark A. Wilson | CHIEF LEGAL OFFICER | -10.00K | $0.67 | -$6.70K | SELL | -3.08% | 314.30K | May 19 | View |
| May 21, 2025 | HOWARD ROBIN | PRESIDENT & CEO | -23.21K | $0.67 | -$15.55K | SELL | -2.13% | 1.06M | May 19 | View |
| Feb 21, 2025 | Jonathan Zalevsky | CHIEF R&D OFFICER | -10.30K | $1.01 | -$10.40K | SELL | -3.15% | 316.60K | Feb 19 | View |
| Feb 21, 2025 | Mark A. Wilson | CHIEF LEGAL OFFICER | -11.04K | $1.01 | -$11.15K | SELL | -3.29% | 324.29K | Feb 19 | View |
| Feb 21, 2025 | HOWARD ROBIN | PRESIDENT & CEO | -23.77K | $1.01 | -$24.01K | SELL | -2.14% | 1.09M | Feb 19 | View |
| Dec 26, 2024 | Mark A. Wilson | CHIEF LEGAL OFFICER | -49.96K | $0.90 | -$44.80K | SELL | -12.97% | 335.33K | Dec 23 - Dec 24 | View |
| Dec 20, 2024 | Jonathan Zalevsky | CHIEF R&D OFFICER | -51.12K | $0.94 | -$48.05K | SELL | -13.52% | 326.90K | Dec 19 | View |
| Dec 19, 2024 | HOWARD ROBIN | PRESIDENT & CEO | -132.03K | $1.00 | -$131.65K | SELL | -10.62% | 1.11M | Dec 17 - Dec 18 | View |
| Nov 20, 2024 | Jonathan Zalevsky | CHIEF R&D OFFICER | -7.79K | $1.01 | -$7.86K | SELL | -3.10% | 243.02K | Nov 19 | View |
| Nov 20, 2024 | Mark A. Wilson | CHIEF LEGAL OFFICER | -6.41K | $1.01 | -$6.47K | SELL | -2.84% | 218.86K | Nov 19 | View |
| Nov 20, 2024 | HOWARD ROBIN | PRESIDENT & CEO | -16.28K | $1.01 | -$16.44K | SELL | -1.92% | 832.49K | Nov 19 | View |
| Aug 20, 2024 | Jonathan Zalevsky | CHIEF R&D OFFICER | -6.87K | $1.28 | -$8.79K | SELL | -2.66% | 250.80K | Aug 19 | View |
| Aug 20, 2024 | Mark A. Wilson | CHIEF LEGAL OFFICER | -5.65K | $1.28 | -$7.23K | SELL | -2.45% | 225.26K | Aug 19 | View |
| Aug 20, 2024 | HOWARD ROBIN | PRESIDENT & CEO | -14.88K | $1.28 | -$19.05K | SELL | -1.72% | 848.77K | Aug 19 | View |
| Jun 14, 2024 | ROBERT CHESS | — | -19.50K | $1.20 | -$23.40K | SELL | -7.04% | 257.37K | Jun 14 | View |
| May 20, 2024 | HOWARD ROBIN | PRESIDENT & CEO | -16.65K | $1.75 | -$29.14K | SELL | -1.89% | 863.65K | May 17 | View |
| May 20, 2024 | Jonathan Zalevsky | CHIEF R&D OFFICER | -7.36K | $1.75 | -$12.87K | SELL | -2.78% | 257.67K | May 17 | View |
| May 20, 2024 | Mark A. Wilson | CHIEF LEGAL OFFICER | -6.26K | $1.75 | -$10.96K | SELL | -2.64% | 230.41K | May 17 | View |
| May 13, 2024 | Deep Track Capital LPDeep Track Biotechnology Master Fund LtdDAVID KROIN | — | -56.00K | $1.78 | -$99.63K | SELL | -0.30% | 18.34M | May 10 | View |
| Feb 22, 2024 | Jonathan Zalevsky | CHIEF R&D OFFICER | -9.01K | $0.68 | -$6.13K | SELL | -3.29% | 265.02K | Feb 20 | View |
| Feb 22, 2024 | Mark A. Wilson | CHIEF LEGAL OFFICER | -7.61K | $0.68 | -$5.17K | SELL | -3.11% | 236.67K | Feb 20 | View |
| Feb 22, 2024 | HOWARD ROBIN | PRESIDENT & CEO | -20.03K | $0.68 | -$13.62K | SELL | -2.23% | 880.30K | Feb 20 | View |
| Nov 20, 2023 | Jonathan Zalevsky | CHIEF R&D OFFICER | -9.65K | $0.49 | -$4.73K | SELL | -3.40% | 274.04K | Nov 17 | View |
| Nov 20, 2023 | Mark A. Wilson | CHIEF LEGAL OFFICER | -7.18K | $0.49 | -$3.52K | SELL | -2.86% | 243.78K | Nov 17 | View |
| Nov 20, 2023 | HOWARD ROBIN | PRESIDENT & CEO | -19.88K | $0.49 | -$9.74K | SELL | -2.16% | 900.33K | Nov 17 | View |
| Sep 20, 2023 | Myriam Curet | DIRECTOR | -4.36K | $0.69 | -$3.01K | SELL | -13.72% | 27.42K | Sep 18 | View |
| Sep 20, 2023 | ROBERT CHESS | DIRECTOR | -10.20K | $0.67 | -$6.83K | SELL | -3.55% | 276.87K | Sep 22 | View |
| Sep 20, 2023 | Robert Jeffrey Ajer | DIRECTOR | -4.36K | $0.69 | -$3.01K | SELL | -11.32% | 34.15K | Sep 18 | View |
| Aug 17, 2023 | Jonathan Zalevsky | CHIEF R&D OFFICER | -9.70K | $0.78 | -$7.57K | SELL | -3.31% | 283.69K | Aug 16 | View |
| Aug 17, 2023 | Mark A. Wilson | CHIEF LEGAL OFFICER | -7.22K | $0.78 | -$5.63K | SELL | -2.80% | 250.96K | Aug 16 | View |
| Aug 17, 2023 | HOWARD ROBIN | PRESIDENT & CEO | -20.00K | $0.78 | -$15.60K | SELL | -2.13% | 920.21K | Aug 16 | View |
| Jun 15, 2023 | ROY WHITFIELD | DIRECTOR | -30.00K | $0.57 | -$17.10K | SELL | -11.27% | 236.25K | Jun 14 | View |
| May 17, 2023 | Jonathan Zalevsky | CHIEF R&D OFFICER | -9.79K | $0.72 | -$7.05K | SELL | -3.23% | 293.39K | May 16 | View |
| May 17, 2023 | Mark A. Wilson | CHIEF LEGAL OFFICER | -7.54K | $0.72 | -$5.43K | SELL | -2.84% | 257.68K | May 16 | View |
| May 17, 2023 | HOWARD ROBIN | PRESIDENT & CEO | -20.36K | $0.72 | -$14.66K | SELL | -2.12% | 940.21K | May 16 | View |
| Feb 17, 2023 | Jonathan Zalevsky | CHIEF R&D OFFICER | -10.48K | $3.00 | -$31.45K | SELL | -3.34% | 303.18K | Feb 16 | View |
| Feb 17, 2023 | Mark A. Wilson | CHIEF LEGAL OFFICER | -8.28K | $3.00 | -$24.82K | SELL | -3.03% | 265.22K | Feb 16 | View |
| Feb 17, 2023 | Jillian Thomsen | CHIEF FINANCIAL OFFICER | -10.27K | $3.00 | -$30.80K | SELL | -3.17% | 313.50K | Feb 16 | View |
| Feb 17, 2023 | HOWARD ROBIN | PRESIDENT & CEO | -19.64K | $3.00 | -$58.91K | SELL | -2.00% | 960.57K | Feb 16 | View |
| Nov 18, 2022 | Jonathan Zalevsky | CHIEF R&D OFFICER | -13.46K | $3.57 | -$48.05K | SELL | -4.11% | 313.66K | Nov 16 | View |
| Nov 18, 2022 | Mark A. Wilson | CHIEF LEGAL OFFICER | -8.69K | $3.57 | -$31.02K | SELL | -3.09% | 272.50K | Nov 16 | View |
| Nov 18, 2022 | Jillian Thomsen | CHIEF FINANCIAL OFFICER | -11.10K | $3.57 | -$39.61K | SELL | -3.31% | 323.76K | Nov 16 | View |
| Nov 18, 2022 | HOWARD ROBIN | PRESIDENT & CEO | -38.01K | $3.57 | -$135.71K | SELL | -3.73% | 980.20K | Nov 16 | View |
| Sep 26, 2022 | Myriam Curet | DIRECTOR | -4.20K | $3.16 | -$13.27K | SELL | -11.67% | 31.78K | Sep 23 | View |
| Sep 26, 2022 | Robert Jeffrey Ajer | DIRECTOR | -4.20K | $3.16 | -$13.27K | SELL | -9.83% | 38.51K | Sep 23 | View |
| Sep 26, 2022 | ROBERT CHESS | DIRECTOR | -5.10K | $3.19 | -$16.27K | SELL | -1.95% | 256.18K | Sep 22 | View |
| Sep 14, 2022 | KARIN EASTHAM | DIRECTOR | -21.27K | $3.61 | -$76.77K | SELL | -62.00% | 13.03K | Sep 13 | View |
| Aug 19, 2022 | Jonathan Zalevsky | CHIEF R&D OFFICER | -73.72K | $4.65 | -$342.78K | SELL | -18.39% | 327.12K | Aug 18 | View |
| Aug 17, 2022 | Jonathan Zalevsky | CHIEF R&D OFFICER | 124.44K | $4.76 | -$50.27K | GRANT | 45.02% | 400.84K | Aug 15 - Aug 16 | View |
| Aug 17, 2022 | Mark A. Wilson | SVP & GENERAL COUNSEL | 162.75K | $4.76 | -$15.18K | GRANT | 137.41% | 281.19K | Aug 15 - Aug 16 | View |
| Aug 17, 2022 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | 163.93K | $4.76 | -$9.55K | GRANT | 95.91% | 334.86K | Aug 15 - Aug 16 | View |
| Aug 17, 2022 | HOWARD ROBIN | PRESIDENT & CEO | 396.87K | $4.76 | -$65.49K | GRANT | 63.87% | 1.02M | Aug 15 - Aug 16 | View |
| May 17, 2022 | Jonathan Zalevsky | CHIEF R&D OFFICER | 2.28K | $3.95 | -$85.61K | GRANT | 0.83% | 276.40K | May 15 - May 16 | View |
| May 17, 2022 | Mark A. Wilson | SVP & GENERAL COUNSEL | -3.14K | $3.95 | -$12.39K | SELL | -2.59% | 117.94K | May 16 | View |
| May 17, 2022 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | 5.11K | $3.95 | -$23.07K | GRANT | 3.09% | 170.43K | May 15 - May 16 | View |
| May 17, 2022 | HOWARD ROBIN | PRESIDENT & CEO | 31.92K | $3.95 | -$144.29K | GRANT | 5.42% | 621.35K | May 15 - May 16 | View |
| May 17, 2022 | JOHN NORTHCOTT | SVP & CHIEF COMMERCIAL OFFICER | -4.59K | $3.95 | -$18.14K | SELL | -2.02% | 223.21K | May 16 | View |
| May 17, 2022 | Gil Labrucherie | SVP, COO & CFO | 11.30K | $3.95 | -$68.92K | GRANT | 3.75% | 312.90K | May 15 - May 16 | View |
| Feb 18, 2022 | Jonathan Zalevsky | CHIEF R&D OFFICER | -10.91K | $10.95 | -$119.49K | SELL | -3.83% | 274.12K | Feb 16 | View |
| Feb 18, 2022 | Mark A. Wilson | SVP & GENERAL COUNSEL | -3.66K | $10.95 | -$40.09K | SELL | -2.93% | 121.08K | Feb 16 | View |
| Feb 18, 2022 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | -2.36K | $10.95 | -$25.87K | SELL | -1.41% | 165.32K | Feb 16 | View |
| Feb 18, 2022 | HOWARD ROBIN | PRESIDENT & CEO | -12.48K | $10.95 | -$136.66K | SELL | -2.07% | 589.43K | Feb 16 | View |
| Feb 18, 2022 | JOHN NORTHCOTT | SVP & CHIEF COMMERCIAL OFFICER | -4.85K | $10.95 | -$53.13K | SELL | -2.09% | 227.80K | Feb 16 | View |
| Feb 18, 2022 | Gil Labrucherie | SVP, COO & CFO | -7.58K | $10.95 | -$82.99K | SELL | -2.45% | 301.60K | Feb 16 | View |
| Nov 18, 2021 | Gil Labrucherie | SVP, COO & CFO | -24.15K | $13.10 | -$316.39K | SELL | -8.60% | 256.68K | Nov 16 - Nov 18 | View |
| Nov 17, 2021 | Jonathan Zalevsky | CHIEF R&D OFFICER | 19.28K | $13.16 | -$274.64K | GRANT | 9.06% | 232.08K | Nov 15 - Nov 16 | View |
| Nov 17, 2021 | Mark A. Wilson | SVP & GENERAL COUNSEL | 13.54K | $13.16 | -$86.38K | GRANT | 18.57% | 86.44K | Nov 15 - Nov 16 | View |
| Nov 17, 2021 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | 8.16K | $13.16 | -$88.71K | GRANT | 5.92% | 145.98K | Nov 15 - Nov 16 | View |
| Nov 17, 2021 | HOWARD ROBIN | PRESIDENT & CEO | 51.33K | $13.16 | -$562.89K | GRANT | 12.09% | 475.86K | Nov 15 - Nov 16 | View |
| Nov 17, 2021 | JOHN NORTHCOTT | SVP & CHIEF COMMERCIAL OFFICER | -6.06K | $13.16 | -$79.76K | SELL | -3.02% | 194.85K | Nov 16 | View |
| Sep 24, 2021 | Myriam Curet | DIRECTOR | 6.54K | $17.78 | -$65.16K | GRANT | 33.97% | 25.77K | Sep 22 | View |
| Sep 24, 2021 | ROBERT CHESS | DIRECTOR | 5.60K | $17.94 | -$82.52K | GRANT | 2.03% | 281.97K | Sep 22 | View |
| Sep 24, 2021 | Robert Jeffrey Ajer | DIRECTOR | 6.54K | $17.78 | -$65.16K | GRANT | 25.16% | 32.51K | Sep 22 | View |
| Sep 10, 2021 | ROBERT CHESS | DIRECTOR | 0.00 | $14.91 | -$40.42K | SELL-OPTIONS | 0.00% | 276.37K | Sep 08 - Sep 09 | View |
| Aug 18, 2021 | Jonathan Zalevsky | CHIEF R&D OFFICER | -7.66K | $13.83 | -$105.97K | SELL | -3.48% | 212.80K | Aug 16 | View |
| Aug 18, 2021 | Mark A. Wilson | SVP & GENERAL COUNSEL | -1.91K | $13.83 | -$26.42K | SELL | -2.55% | 72.90K | Aug 16 | View |
| Aug 18, 2021 | HOWARD ROBIN | PRESIDENT & CEO | -11.52K | $13.83 | -$159.25K | SELL | -2.64% | 424.53K | Aug 16 | View |
| Aug 18, 2021 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | -13.34K | $13.83 | -$184.48K | SELL | -8.82% | 137.82K | Aug 16 | View |
| Aug 18, 2021 | JOHN NORTHCOTT | SVP & CHIEF COMMERCIAL OFFICER | -6.19K | $13.83 | -$85.64K | SELL | -2.99% | 200.91K | Aug 16 | View |
| Aug 18, 2021 | Gil Labrucherie | SVP, COO & CFO | -10.87K | $13.76 | -$149.48K | SELL | -4.33% | 240.23K | Aug 16 - Aug 17 | View |
| Jul 22, 2021 | ROBERT CHESS | DIRECTOR | 0.00 | $15.30 | -$17.20K | SELL-OPTIONS | 0.00% | 280.57K | Jul 20 - Jul 22 | View |
| May 19, 2021 | Jonathan Zalevsky | CHIEF R&D OFFICER | -31.11K | $18.30 | -$569.33K | SELL | -11.69% | 235.06K | May 17 | View |
| May 19, 2021 | Mark A. Wilson | SVP & GENERAL COUNSEL | -1.92K | $18.30 | -$35.08K | SELL | -2.50% | 74.81K | May 17 | View |
| May 19, 2021 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | -13.39K | $18.30 | -$245.06K | SELL | -8.14% | 151.16K | May 17 | View |
| May 19, 2021 | HOWARD ROBIN | PRESIDENT & CEO | -11.56K | $18.30 | -$211.55K | SELL | -2.58% | 436.05K | May 17 | View |
| May 19, 2021 | JOHN NORTHCOTT | SVP & CHIEF COMMERCIAL OFFICER | -6.08K | $18.30 | -$111.36K | SELL | -2.85% | 207.11K | May 17 | View |
| May 19, 2021 | Gil Labrucherie | SVP, COO & CFO | -7.90K | $18.30 | -$144.53K | SELL | -3.05% | 251.10K | May 17 | View |
| May 14, 2021 | ROBERT CHESS | DIRECTOR | 0.00 | $16.57 | -$44.32K | SELL-OPTIONS | 0.00% | 280.57K | May 12 | View |
| Apr 16, 2021 | ROBERT CHESS | DIRECTOR | 0.00 | $16.39 | -$41.44K | SELL-OPTIONS | 0.00% | 280.57K | Apr 14 | View |
| Feb 18, 2021 | Jonathan Zalevsky | CHIEF R&D OFFICER | -24.14K | $22.37 | -$540.03K | SELL | -8.32% | 266.18K | Feb 16 | View |
| Feb 18, 2021 | Mark A. Wilson | SVP & GENERAL COUNSEL | -2.17K | $22.37 | -$48.61K | SELL | -2.75% | 76.73K | Feb 16 | View |
| Feb 18, 2021 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | -11.71K | $22.37 | -$261.84K | SELL | -6.64% | 164.55K | Feb 16 | View |
| Feb 18, 2021 | HOWARD ROBIN | PRESIDENT & CEO | -11.49K | $22.37 | -$257.14K | SELL | -2.50% | 447.61K | Feb 16 | View |
| Feb 18, 2021 | JOHN NORTHCOTT | SVP & CHIEF COMMERCIAL OFFICER | -15.36K | $22.37 | -$343.56K | SELL | -6.72% | 213.19K | Feb 16 | View |
| Feb 18, 2021 | Gil Labrucherie | SVP, COO & CFO | -7.98K | $22.37 | -$178.45K | SELL | -2.99% | 259.00K | Feb 16 | View |
| Feb 04, 2021 | Mark A. Wilson | SVP & GENERAL COUNSEL | -10.69K | $14.13 | -$150.97K | SELL | -11.93% | 78.90K | Feb 03 | View |
| Feb 04, 2021 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $14.36 | -$5.01M | SELL-OPTIONS | 0.00% | 459.10K | Feb 02 - Feb 04 | View |
| Feb 04, 2021 | Gil Labrucherie | SVP, COO & CFO | 0.00 | $14.33 | -$1.66M | SELL-OPTIONS | 0.00% | 266.97K | Feb 02 - Feb 04 | View |
| Jan 29, 2021 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | 0.00 | $13.71 | -$736.50K | SELL-OPTIONS | 0.00% | 176.26K | Jan 28 | View |
| Dec 17, 2020 | Curet Myriam | — | -1.56K | $17.82 | -$27.80K | SELL | -7.50% | 19.24K | Dec 15 | View |
| Nov 25, 2020 | Jonathan Zalevsky | — | -16.38K | $16.40 | -$268.63K | SELL | -6.14% | 250.32K | Nov 23 | View |
| Nov 18, 2020 | Jonathan Zalevsky | — | -29.62K | $16.93 | -$501.43K | SELL | -10.00% | 266.70K | Nov 16 | View |
| Nov 18, 2020 | Mark A. Wilson Attorney-in-Fact | — | -1.54K | $16.93 | -$26.06K | SELL | -2.99% | 49.85K | Nov 16 | View |
| Nov 18, 2020 | Jillian Thomsen | — | -11.98K | $16.93 | -$202.75K | SELL | -6.97% | 159.76K | Nov 16 | View |
| Nov 18, 2020 | HOWARD ROBIN | — | -11.97K | $16.93 | -$202.74K | SELL | -3.29% | 352.45K | Nov 16 | View |
| Nov 18, 2020 | Gil Labrucherie | — | -8.28K | $16.93 | -$140.11K | SELL | -3.52% | 226.97K | Nov 16 | View |
| Sep 30, 2020 | Robert Jeffrey Ajer | — | -3.25K | $17.25 | -$56.06K | SELL | -11.12% | 25.98K | Sep 28 | View |
| Sep 25, 2020 | ROBERT CHESS | — | -5.50K | $17.75 | -$97.63K | SELL | -1.92% | 280.57K | Sep 25 | View |
| Sep 21, 2020 | Gil Labrucherie | — | -2.00K | $19.96 | -$39.92K | SELL | -0.84% | 235.25K | Sep 17 | View |
| Sep 21, 2020 | Robert Jeffrey Ajer | — | -2.25K | $19.74 | -$44.41K | SELL | -10.06% | 20.13K | Sep 21 | View |
| Sep 10, 2020 | ROBERT CHESS | — | 0.00 | $13.89 | -$74.32K | OPTION EXERCISE | 0.00% | 276.97K | Sep 08 | View |
| Aug 19, 2020 | Jonathan Zalevsky | — | -26.20K | $19.67 | -$515.35K | SELL | -8.12% | 296.31K | Aug 17 | View |
| Aug 19, 2020 | Mark A. Wilson Attorney-in-Fact | — | -1.53K | $19.67 | -$30.08K | SELL | -2.89% | 51.39K | Aug 17 | View |
| Aug 19, 2020 | Jillian Thomsen | — | -1.37K | $19.67 | -$26.89K | SELL | -0.79% | 171.73K | Aug 17 | View |
| Aug 19, 2020 | HOWARD ROBIN | — | -11.88K | $19.67 | -$233.78K | SELL | -3.16% | 364.43K | Aug 17 | View |
| Aug 19, 2020 | Gil Labrucherie | — | -8.24K | $19.67 | -$162.20K | SELL | -3.36% | 237.25K | Aug 17 - Aug 18 | View |
| Jul 10, 2020 | SCOTT GREER | — | 24.99K | $17.12 | -$5.63K | OPTION EXERCISE | 16.49% | 176.57K | Jul 09 | View |
| Jul 10, 2020 | ROBERT CHESS | — | 0.00 | $16.91 | -$122.72K | OPTION EXERCISE | 0.00% | 276.97K | Jul 08 | View |
| May 20, 2020 | Jonathan Zalevsky | — | -4.56K | $22.51 | -$102.60K | SELL | -1.39% | 322.51K | May 18 | View |
| May 20, 2020 | Mark A. Wilson Attorney-in-Fact | — | -1.53K | $22.51 | -$34.42K | SELL | -2.83% | 52.42K | May 18 | View |
| May 20, 2020 | Jillian Thomsen | — | -1.37K | $22.51 | -$30.77K | SELL | -0.79% | 172.72K | May 18 | View |
| May 20, 2020 | HOWARD ROBIN | — | -8.97K | $22.51 | -$201.87K | SELL | -2.33% | 376.31K | May 18 | View |
| May 20, 2020 | Gil Labrucherie | — | -7.73K | $22.54 | -$174.15K | SELL | -3.05% | 245.49K | May 18 - May 19 | View |
| Apr 17, 2020 | ROBERT CHESS | — | -16.00K | $13.81 | -$220.93K | OPTION EXERCISE | -5.46% | 276.97K | Apr 15 | View |
| Mar 13, 2020 | ROBERT CHESS | — | -16.00K | $13.01 | -$208.24K | OPTION EXERCISE | -5.46% | 276.97K | Mar 11 | View |
| Feb 20, 2020 | Jonathan Zalevsky | — | -4.77K | $22.35 | -$106.70K | SELL | -1.44% | 327.07K | Feb 18 | View |
| Feb 20, 2020 | Jillian Thomsen | — | -1.39K | $22.35 | -$31.16K | SELL | -0.79% | 174.09K | Feb 18 | View |
| Feb 20, 2020 | HOWARD ROBIN | — | -8.45K | $22.35 | -$188.81K | SELL | -2.15% | 385.28K | Feb 18 | View |
| Feb 20, 2020 | Gil Labrucherie | — | -5.94K | $22.35 | -$132.71K | SELL | -2.29% | 253.22K | Feb 18 | View |
| Feb 14, 2020 | ROBERT CHESS | — | -16.00K | $16.37 | -$261.92K | OPTION EXERCISE | -5.46% | 276.97K | Feb 12 | View |
| Feb 07, 2020 | Jillian Thomsen | — | 0.00 | $15.00 | -$583.88K | OPTION EXERCISE | 0.00% | 175.48K | Feb 06 | View |
| Nov 20, 2019 | Jonathan Zalevsky | CHIEF R&D OFFICER | -3.96K | $17.97 | -$71.16K | SELL | -1.34% | 291.70K | Nov 18 | View |
| Nov 20, 2019 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | -2.71K | $17.97 | -$48.75K | SELL | -1.66% | 160.44K | Nov 18 | View |
| Nov 20, 2019 | HOWARD ROBIN | PRESIDENT & CEO | -13.56K | $17.97 | -$243.60K | SELL | -4.33% | 299.63K | Nov 18 | View |
| Nov 20, 2019 | Gil Labrucherie | SVP, COO & CFO | -8.86K | $17.97 | -$159.27K | SELL | -3.89% | 219.01K | Nov 18 | View |
| Nov 15, 2019 | Gil Labrucherie | SVP, COO & CFO | 0.00 | $13.50 | -$314.50K | SELL-OPTIONS | 0.00% | 227.87K | Nov 13 | View |
| Oct 17, 2019 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $12.29 | -$1.02M | SELL-OPTIONS | 0.00% | 313.19K | Oct 15 - Oct 17 | View |
| Oct 17, 2019 | Gil Labrucherie | SVP, COO & CFO | 0.00 | $11.52 | -$215.50K | SELL-OPTIONS | 0.00% | 227.87K | Oct 15 | View |
| Oct 02, 2019 | Lutz Lingnau | DIRECTOR | -3.00K | $17.84 | -$53.52K | SELL | -10.10% | 26.70K | Sep 27 | View |
| Oct 01, 2019 | Robert Jeffrey Ajer | DIRECTOR | -2.38K | $18.06 | -$42.89K | SELL | -9.60% | 22.38K | Sep 30 | View |
| Oct 01, 2019 | ROBERT CHESS | DIRECTOR | -4.00K | $17.99 | -$71.96K | SELL | -1.42% | 276.97K | Sep 27 | View |
| Sep 24, 2019 | Robert Jeffrey Ajer | DIRECTOR | -2.25K | $20.24 | -$45.54K | SELL | -10.98% | 18.25K | Sep 20 | View |
| Sep 18, 2019 | Gil Labrucherie | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $13.87 | -$332.75K | SELL-OPTIONS | 0.00% | 152.87K | Sep 16 | View |
| Sep 09, 2019 | Stephen Doberstein | SVP & CHIEF SCIENTIFIC OFFICER | 15.00K | $17.28 | $259.20K | BUY | 16.19% | 107.67K | Sep 05 | View |
| Aug 19, 2019 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | -1.81K | $18.15 | -$32.83K | SELL | -1.10% | 163.15K | Aug 16 | View |
| Aug 19, 2019 | HOWARD ROBIN | PRESIDENT & CEO | -12.55K | $18.15 | -$227.80K | SELL | -4.24% | 283.19K | Aug 16 | View |
| Aug 19, 2019 | John Nicholson | SVP & CHIEF OPERATING OFFICER | -3.82K | $18.15 | -$69.31K | SELL | -2.29% | 162.76K | Aug 16 | View |
| Aug 19, 2019 | Gil Labrucherie | SVP & CHIEF FINANCIAL OFFICER | -5.06K | $18.15 | -$91.89K | SELL | -3.96% | 122.87K | Aug 16 | View |
| Aug 19, 2019 | Stephen Doberstein | SVP & CHIEF SCIENTIFIC OFFICER | -3.25K | $18.15 | -$58.90K | SELL | -3.38% | 92.67K | Aug 16 | View |
| Aug 16, 2019 | Gil Labrucherie | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $12.50 | -$264.50K | SELL-OPTIONS | 0.00% | 127.94K | Aug 14 | View |
| Jul 25, 2019 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $19.25 | -$2.41M | SELL-OPTIONS | 0.00% | 295.74K | Jul 23 - Jul 25 | View |
| Jul 12, 2019 | Gil Labrucherie | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $20.89 | -$684.00K | SELL-OPTIONS | 0.00% | 127.94K | Jul 10 | View |
| Jul 10, 2019 | Lutz Lingnau | DIRECTOR | 0.00 | $21.94 | -$253.90K | SELL-OPTIONS | 0.00% | 23.20K | Jul 08 | View |
| Jun 19, 2019 | Gil Labrucherie | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $20.46 | -$662.50K | SELL-OPTIONS | 0.00% | 127.94K | Jun 17 | View |
| May 23, 2019 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $20.11 | -$2.58M | SELL-OPTIONS | 0.00% | 295.74K | May 21 - May 23 | View |
| May 17, 2019 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | -1.93K | $31.37 | -$60.48K | SELL | -1.16% | 164.46K | May 16 | View |
| May 17, 2019 | HOWARD ROBIN | PRESIDENT & CEO | -13.38K | $31.37 | -$419.82K | SELL | -4.33% | 295.74K | May 16 | View |
| May 17, 2019 | John Nicholson | SVP & CHIEF OPERATING OFFICER | -4.08K | $31.37 | -$127.90K | SELL | -2.39% | 166.58K | May 16 | View |
| May 17, 2019 | Gil Labrucherie | SVP & CHIEF FINANCIAL OFFICER | -3.77K | $31.37 | -$118.17K | SELL | -2.86% | 127.94K | May 16 | View |
| May 17, 2019 | Maninder Hora | SVP PHARMA DEV & MFG OPS | -2.45K | $31.37 | -$76.83K | SELL | -2.52% | 94.69K | May 16 | View |
| May 17, 2019 | Stephen Doberstein | SVP & CHIEF SCIENTIFIC OFFICER | -3.46K | $31.37 | -$108.57K | SELL | -3.48% | 95.91K | May 16 | View |
| Feb 21, 2019 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | -1.81K | $42.39 | -$76.64K | SELL | -1.07% | 166.39K | Feb 19 | View |
| Feb 21, 2019 | HOWARD ROBIN | PRESIDENT & CEO | -8.88K | $24.70 | -$3.87M | SELL | -2.79% | 309.12K | Feb 19 - Feb 21 | View |
| Feb 21, 2019 | John Nicholson | SVP & CHIEF OPERATING OFFICER | -3.82K | $42.39 | -$162.01K | SELL | -2.19% | 170.66K | Feb 19 | View |
| Feb 21, 2019 | Gil Labrucherie | SVP & CHIEF FINANCIAL OFFICER | -3.59K | $42.39 | -$152.26K | SELL | -2.65% | 131.70K | Feb 19 | View |
| Feb 21, 2019 | Maninder Hora | SVP PHARMA DEV & MFG OPS | -2.39K | $42.39 | -$101.14K | SELL | -2.40% | 97.14K | Feb 19 | View |
| Feb 21, 2019 | Stephen Doberstein | SVP & CHIEF SCIENTIFIC OFFICER | -3.31K | $42.39 | -$140.31K | SELL | -3.22% | 99.37K | Feb 19 | View |
| Feb 06, 2019 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | 0.00 | $26.42 | -$507.26K | SELL-OPTIONS | 0.00% | 168.20K | Feb 04 | View |
| Jan 30, 2019 | John Nicholson | SVP & CHIEF OPERATING OFFICER | 0.00 | $26.75 | -$2.02M | SELL-OPTIONS | 0.00% | 174.48K | Jan 28 | View |
| Nov 19, 2018 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | -4.02K | $38.25 | -$153.61K | SELL | -2.49% | 157.25K | Nov 16 | View |
| Nov 19, 2018 | HOWARD ROBIN | PRESIDENT & CEO | -15.33K | $38.25 | -$586.22K | SELL | -5.79% | 249.55K | Nov 16 | View |
| Nov 19, 2018 | John Nicholson | SVP & CHIEF OPERATING OFFICER | -5.98K | $38.25 | -$228.81K | SELL | -3.31% | 174.48K | Nov 16 | View |
| Nov 19, 2018 | Gil Labrucherie | SVP & CHIEF FINANCIAL OFFICER | -6.51K | $38.25 | -$249.20K | SELL | -5.76% | 106.54K | Nov 16 | View |
| Nov 19, 2018 | Maninder Hora | SVP PHARMA DEV & MFG OPS | -4.69K | $38.25 | -$179.55K | SELL | -5.48% | 81.03K | Nov 16 | View |
| Nov 19, 2018 | Stephen Doberstein | SVP & CHIEF SCIENTIFIC OFFICER | -4.52K | $38.25 | -$173.04K | SELL | -5.43% | 78.73K | Nov 16 | View |
| Sep 21, 2018 | Lutz Lingnau | DIRECTOR | -9.00K | $56.98 | -$512.82K | SELL | -32.79% | 18.45K | Sep 20 | View |
| Sep 21, 2018 | ROBERT CHESS | DIRECTOR | -4.50K | $56.81 | -$255.65K | SELL | -1.64% | 269.72K | Sep 19 | View |
| Sep 21, 2018 | Robert Jeffrey Ajer | DIRECTOR | -6.75K | $56.76 | -$383.13K | SELL | -30.00% | 15.75K | Sep 20 | View |
| Sep 06, 2018 | SCOTT GREER | DIRECTOR | 0.00 | $36.27 | -$622.50K | SELL-OPTIONS | 0.00% | 130.33K | Sep 04 | View |
| Aug 21, 2018 | DENNIS WINGER | DIRECTOR | 0.00 | $37.11 | -$1.37M | SELL-OPTIONS | 0.00% | 47.75K | Aug 17 - Aug 21 | View |
| Aug 15, 2018 | DENNIS WINGER | DIRECTOR | -34.25K | $60.59 | -$2.08M | SELL | -41.77% | 47.75K | Aug 13 - Aug 14 | View |
| Jun 27, 2018 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $30.11 | -$5.05M | SELL-OPTIONS | 0.00% | 224.77K | Jun 25 - Jun 27 | View |
| Jun 07, 2018 | ROY WHITFIELD | DIRECTOR | 5.00K | $58.04 | $290.21K | BUY | 2.60% | 197.00K | Jun 05 - Jun 06 | View |
| Jun 07, 2018 | ROBERT CHESS | DIRECTOR | 0.00 | $34.71 | -$409.00K | SELL-OPTIONS | 0.00% | 274.22K | Jun 05 | View |
| Jun 06, 2018 | SCOTT GREER | DIRECTOR | 0.00 | $32.71 | -$551.39K | SELL-OPTIONS | 0.00% | 130.33K | Jun 04 - Jun 06 | View |
| May 18, 2018 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | -3.58K | $83.39 | -$298.20K | SELL | -5.19% | 65.28K | May 16 | View |
| May 18, 2018 | HOWARD ROBIN | PRESIDENT & CEO | -12.79K | $83.39 | -$1.07M | SELL | -5.38% | 224.77K | May 16 | View |
| May 18, 2018 | John Nicholson | SVP & CHIEF OPERATING OFFICER | -4.92K | $83.39 | -$410.03K | SELL | -2.94% | 162.60K | May 16 | View |
| May 18, 2018 | Gil Labrucherie | SVP & CHIEF FINANCIAL OFFICER | -4.94K | $83.39 | -$412.03K | SELL | -4.95% | 94.80K | May 16 | View |
| May 18, 2018 | Maninder Hora | SVP PHARMA DEV & MFG OPS | -4.06K | $83.39 | -$338.56K | SELL | -5.06% | 76.20K | May 16 | View |
| May 18, 2018 | Stephen Doberstein | SVP & CHIEF SCIENTIFIC OFFICER | -3.44K | $83.39 | -$286.44K | SELL | -5.10% | 63.96K | May 16 | View |
| May 04, 2018 | ROBERT CHESS | DIRECTOR | 0.00 | $45.80 | -$1.85M | SELL-OPTIONS | 0.00% | 274.22K | May 03 | View |
| May 03, 2018 | Gil Labrucherie | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $47.37 | -$6.60M | SELL-OPTIONS | 0.00% | 99.74K | May 01 - May 03 | View |
| May 03, 2018 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $47.37 | -$9.54M | SELL-OPTIONS | 0.00% | 237.56K | May 01 - May 03 | View |
| Apr 18, 2018 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | 0.00 | $56.07 | -$1.26M | SELL-OPTIONS | 0.00% | 68.86K | Apr 16 | View |
| Apr 12, 2018 | Maninder Hora | SVP PHARMA DEV & MFG OPS | 0.00 | $56.44 | -$49.43K | SELL-OPTIONS | 0.00% | 80.26K | Apr 10 | View |
| Apr 09, 2018 | Lutz Lingnau | DIRECTOR | 0.00 | $55.49 | -$2.77M | SELL-OPTIONS | 0.00% | 27.45K | Apr 05 | View |
| Apr 09, 2018 | Maninder Hora | SVP PHARMA DEV & MFG OPS | 0.00 | $55.01 | -$2.82M | SELL-OPTIONS | 0.00% | 80.26K | Apr 05 - Apr 09 | View |
| Apr 09, 2018 | SCOTT GREER | DIRECTOR | 0.00 | $53.24 | -$2.34M | SELL-OPTIONS | 0.00% | 130.33K | Apr 06 | View |
| Apr 09, 2018 | Stephen Doberstein | SVP & CHIEF SCIENTIFIC OFFICER | 0.00 | $50.79 | -$13.53M | SELL-OPTIONS | 0.00% | 67.39K | Apr 06 - Apr 09 | View |
| Apr 09, 2018 | ROBERT CHESS | DIRECTOR | 0.00 | $50.47 | -$2.08M | SELL-OPTIONS | 0.00% | 274.22K | Apr 06 | View |
| Mar 08, 2018 | CHRISTOPHER KUEBLER | DIRECTOR | 0.00 | $51.88 | -$3.66M | SELL-OPTIONS | 0.00% | 40.50K | Mar 06 - Mar 07 | View |
| Mar 08, 2018 | John Nicholson | SVP & CHIEF OPERATING OFFICER | -220.14K | $99.27 | -$21.85M | SELL | -56.79% | 167.51K | Mar 06 - Mar 07 | View |
| Feb 20, 2018 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | -2.54K | $82.94 | -$211.08K | SELL | -3.56% | 68.86K | Feb 16 | View |
| Feb 20, 2018 | HOWARD ROBIN | PRESIDENT & CEO | -12.79K | $82.94 | -$1.06M | SELL | -5.11% | 237.56K | Feb 16 | View |
| Feb 20, 2018 | John Nicholson | SVP & CHIEF OPERATING OFFICER | -4.88K | $82.94 | -$404.66K | SELL | -1.24% | 387.66K | Feb 16 | View |
| Feb 20, 2018 | Gil Labrucherie | SVP & CHIEF FINANCIAL OFFICER | -3.48K | $82.94 | -$288.38K | SELL | -3.37% | 99.74K | Feb 16 | View |
| Feb 20, 2018 | Maninder Hora | SVP PHARMA DEV & MFG OPS | -2.88K | $82.94 | -$238.45K | SELL | -3.46% | 80.26K | Feb 16 | View |
| Feb 20, 2018 | Stephen Doberstein | SVP & CHIEF SCIENTIFIC OFFICER | -2.43K | $82.94 | -$201.21K | SELL | -3.47% | 67.39K | Feb 16 | View |
| Jan 24, 2018 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $43.58 | -$5.37M | SELL-OPTIONS | 0.00% | 250.34K | Jan 22 | View |
| Jan 04, 2018 | CHRISTOPHER KUEBLER | DIRECTOR | 0.00 | $36.46 | -$1.33M | SELL-OPTIONS | 0.00% | 40.50K | Jan 02 | View |
| Dec 15, 2017 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $33.52 | -$3.70M | SELL-OPTIONS | 0.00% | 189.84K | Dec 13 | View |
| Nov 15, 2017 | John Nicholson | SVP & CHIEF OPERATING OFFICER | 9.09K | $23.51 | -$370.08K | SELL-OPTIONS | 4.06% | 233.16K | Nov 13 | View |
| Nov 08, 2017 | Maninder Hora | SVP PHARMA DEV & MFG OPS | 0.00 | $18.05 | -$329.97K | SELL-OPTIONS | 0.00% | 58.23K | Nov 06 - Nov 07 | View |
| Nov 08, 2017 | Stephen Doberstein | SVP & CHIEF SCIENTIFIC OFFICER | 0.00 | $19.27 | -$7.72M | SELL-OPTIONS | 0.00% | 31.10K | Nov 06 - Nov 08 | View |
| Nov 03, 2017 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $17.45 | -$1.02M | SELL-OPTIONS | 0.00% | 152.91K | Nov 01 | View |
| Oct 10, 2017 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $17.77 | -$1.07M | SELL-OPTIONS | 0.00% | 152.91K | Oct 09 | View |
| Oct 10, 2017 | Maninder Hora | SVP PHARMA DEV & MFG OPS | 0.00 | $17.84 | -$108.51K | SELL-OPTIONS | 0.00% | 58.23K | Oct 05 | View |
| Oct 10, 2017 | Stephen Doberstein | SVP & CHIEF SCIENTIFIC OFFICER | 0.00 | $17.25 | -$674.37K | SELL-OPTIONS | 0.00% | 31.10K | Oct 05 | View |
| Oct 03, 2017 | Gil Labrucherie | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $17.89 | -$1.57M | SELL-OPTIONS | 0.00% | 63.41K | Oct 02 | View |
| Oct 03, 2017 | Ivan Gergel | SVP & CHIEF MEDICAL OFFICER | 0.00 | $17.59 | -$1.31M | SELL-OPTIONS | 0.00% | 41.58K | Sep 29 - Oct 02 | View |
| Sep 25, 2017 | Lutz Lingnau | DIRECTOR | -5.00K | $21.97 | -$109.85K | SELL | -15.41% | 27.45K | Sep 22 | View |
| Sep 25, 2017 | CHRISTOPHER KUEBLER | DIRECTOR | -4.00K | $21.86 | -$87.44K | SELL | -8.99% | 40.50K | Sep 22 | View |
| Sep 25, 2017 | ROBERT CHESS | DIRECTOR | -6.40K | $21.72 | -$139.01K | SELL | -2.28% | 274.22K | Sep 21 | View |
| Sep 08, 2017 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $16.44 | -$850.00K | SELL-OPTIONS | 0.00% | 152.91K | Sep 06 | View |
| Aug 18, 2017 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | -2.65K | $19.32 | -$51.16K | SELL | -4.95% | 50.84K | Aug 16 | View |
| Aug 18, 2017 | HOWARD ROBIN | PRESIDENT & CEO | -8.38K | $15.30 | -$821.07K | SELL | -5.20% | 152.91K | Aug 16 | View |
| Aug 18, 2017 | John Nicholson | SVP & CHIEF OPERATING OFFICER | -3.18K | $19.32 | -$61.38K | SELL | -1.40% | 224.07K | Aug 16 | View |
| Aug 18, 2017 | Gil Labrucherie | SVP & CHIEF FINANCIAL OFFICER | -3.18K | $19.32 | -$61.38K | SELL | -4.77% | 63.41K | Aug 16 | View |
| Aug 18, 2017 | Maninder Hora | SVP PHARMA DEV & MFG OPS | -2.96K | $19.32 | -$57.11K | SELL | -4.83% | 58.23K | Aug 16 | View |
| Aug 18, 2017 | Ivan Gergel | SVP & CHIEF MEDICAL OFFICER | -2.00K | $19.32 | -$38.58K | SELL | -4.58% | 41.58K | Aug 16 | View |
| Aug 18, 2017 | Stephen Doberstein | SVP & CHIEF SCIENTIFIC OFFICER | -1.70K | $19.32 | -$32.86K | SELL | -5.19% | 31.10K | Aug 16 | View |
| Aug 14, 2017 | ROY WHITFIELD | DIRECTOR | 35.00K | $17.95 | $628.25K | BUY | 29.66% | 153.00K | Aug 10 | View |
| Jul 20, 2017 | Ivan Gergel | SVP & CHIEF MEDICAL OFFICER | 0.00 | $16.07 | -$552.50K | SELL-OPTIONS | 0.00% | 43.57K | Jul 18 | View |
| Jul 18, 2017 | Lutz Lingnau | DIRECTOR | 0.00 | $17.51 | -$195.00K | SELL-OPTIONS | 0.00% | 23.45K | Jul 14 | View |
| Jul 13, 2017 | Ivan Gergel | SVP & CHIEF MEDICAL OFFICER | 0.00 | $16.06 | -$452.63K | SELL-OPTIONS | 0.00% | 43.57K | Jul 11 - Jul 12 | View |
| Jun 09, 2017 | John Nicholson | SVP & CHIEF OPERATING OFFICER | 48.30K | $12.79 | -$1.01M | SELL-OPTIONS | 26.99% | 227.24K | Jun 07 | View |
| May 18, 2017 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | -2.65K | $19.55 | -$51.83K | SELL | -4.76% | 52.99K | May 16 | View |
| May 18, 2017 | HOWARD ROBIN | PRESIDENT & CEO | -8.39K | $19.55 | -$163.99K | SELL | -4.94% | 161.29K | May 16 | View |
| May 18, 2017 | John Nicholson | SVP & CHIEF OPERATING OFFICER | -3.15K | $19.55 | -$61.50K | SELL | -1.73% | 178.94K | May 16 | View |
| May 18, 2017 | Gil Labrucherie | SVP & CHIEF FINANCIAL OFFICER | -3.18K | $19.55 | -$62.15K | SELL | -4.59% | 66.09K | May 16 | View |
| May 18, 2017 | Maninder Hora | SVP PHARMA DEV & MFG OPS | -2.96K | $19.55 | -$57.85K | SELL | -4.65% | 60.69K | May 16 | View |
| May 18, 2017 | Ivan Gergel | SVP & CHIEF MEDICAL OFFICER | -1.45K | $19.55 | -$28.35K | SELL | -3.22% | 43.57K | May 16 | View |
| May 18, 2017 | Stephen Doberstein | SVP & CHIEF SCIENTIFIC OFFICER | -1.70K | $19.55 | -$33.25K | SELL | -4.93% | 32.80K | May 16 | View |
| May 17, 2017 | ROBERT CHESS | DIRECTOR | 0.00 | $14.08 | -$57.10K | SELL-OPTIONS | 0.00% | 271.62K | May 15 | View |
| Apr 19, 2017 | ROBERT CHESS | DIRECTOR | 0.00 | $13.54 | -$51.75K | SELL-OPTIONS | 0.00% | 271.62K | Apr 17 | View |
| Apr 11, 2017 | Lutz Lingnau | DIRECTOR | -7.00K | $20.05 | -$140.35K | SELL | -22.99% | 23.45K | Apr 07 | View |
| Apr 07, 2017 | Stephen Doberstein | SVP & CHIEF SCIENTIFIC OFFICER | 0.00 | $15.61 | -$1.22M | SELL-OPTIONS | 0.00% | 34.50K | Apr 05 | View |
| Apr 07, 2017 | Maninder Hora | SVP PHARMA DEV & MFG OPS | 0.00 | $17.70 | -$1.44M | SELL-OPTIONS | 0.00% | 63.65K | Apr 05 | View |
| Apr 07, 2017 | CHRISTOPHER KUEBLER | DIRECTOR | 0.00 | $15.13 | -$202.65K | SELL-OPTIONS | 0.00% | 35.50K | Apr 05 | View |
| Mar 22, 2017 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | 0.00 | $14.83 | -$1.09M | SELL-OPTIONS | 0.00% | 55.64K | Mar 20 | View |
| Mar 16, 2017 | ROBERT CHESS | DIRECTOR | 0.00 | $11.89 | -$35.20K | SELL-OPTIONS | 0.00% | 271.62K | Mar 14 | View |
| Mar 03, 2017 | Gil Labrucherie | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $10.93 | -$1.69M | SELL-OPTIONS | 0.00% | 69.27K | Mar 02 - Mar 03 | View |
| Feb 23, 2017 | Lutz Lingnau | DIRECTOR | 0.00 | $9.11 | -$238.20K | SELL-OPTIONS | 0.00% | 30.45K | Feb 21 | View |
| Feb 17, 2017 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | -1.97K | $13.14 | -$25.82K | SELL | -3.41% | 55.64K | Feb 16 | View |
| Feb 17, 2017 | HOWARD ROBIN | PRESIDENT & CEO | -8.64K | $13.14 | -$113.48K | SELL | -4.84% | 169.68K | Feb 16 | View |
| Feb 17, 2017 | John Nicholson | SVP & CHIEF OPERATING OFFICER | -3.24K | $13.14 | -$42.53K | SELL | -1.75% | 182.09K | Feb 16 | View |
| Feb 17, 2017 | Gil Labrucherie | SVP & CHIEF FINANCIAL OFFICER | -2.36K | $13.14 | -$31.00K | SELL | -3.29% | 69.27K | Feb 16 | View |
| Feb 17, 2017 | Maninder Hora | SVP PHARMA DEV & MFG OPS | -2.19K | $13.14 | -$28.84K | SELL | -3.33% | 63.65K | Feb 16 | View |
| Feb 17, 2017 | Ivan Gergel | SVP & CHIEF MEDICAL OFFICER | -1.46K | $13.14 | -$19.14K | SELL | -3.13% | 45.02K | Feb 16 | View |
| Feb 17, 2017 | Stephen Doberstein | SVP & CHIEF SCIENTIFIC OFFICER | -1.26K | $13.14 | -$16.57K | SELL | -3.53% | 34.50K | Feb 16 | View |
| Feb 10, 2017 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $8.84 | -$734.13K | SELL-OPTIONS | 0.00% | 178.32K | Feb 08 | View |
| Feb 06, 2017 | John Nicholson | SVP & CHIEF OPERATING OFFICER | 0.00 | $8.52 | -$580.60K | SELL-OPTIONS | 0.00% | 140.33K | Feb 02 - Feb 03 | View |
| Jan 19, 2017 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $8.50 | -$673.75K | SELL-OPTIONS | 0.00% | 178.32K | Jan 17 | View |
| Dec 09, 2016 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $8.45 | -$664.13K | SELL-OPTIONS | 0.00% | 123.32K | Dec 07 | View |
| Nov 18, 2016 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | -1.99K | $13.96 | -$27.72K | SELL | -4.50% | 42.10K | Nov 16 | View |
| Nov 18, 2016 | HOWARD ROBIN | PRESIDENT & CEO | -5.96K | $9.26 | -$889.92K | SELL | -4.61% | 123.32K | Nov 16 - Nov 17 | View |
| Nov 18, 2016 | John Nicholson | SVP & CHIEF OPERATING OFFICER | -1.65K | $13.96 | -$23.09K | SELL | -1.36% | 120.33K | Nov 16 | View |
| Nov 18, 2016 | Gil Labrucherie | SVP & CHIEF FINANCIAL OFFICER | -1.65K | $13.96 | -$23.09K | SELL | -3.13% | 51.13K | Nov 16 | View |
| Nov 18, 2016 | Maninder Hora | SVP PHARMA DEV & MFG OPS | -1.65K | $13.96 | -$23.09K | SELL | -3.18% | 50.34K | Nov 16 | View |
| Nov 18, 2016 | Ivan Gergel | SVP & CHIEF MEDICAL OFFICER | -848.00 | $13.96 | -$11.84K | SELL | -3.10% | 26.48K | Nov 16 | View |
| Nov 18, 2016 | Stephen Doberstein | SVP & CHIEF SCIENTIFIC OFFICER | -670.00 | $13.96 | -$9.35K | SELL | -3.54% | 18.27K | Nov 16 | View |
| Oct 25, 2016 | SCOTT GREER | DIRECTOR | 15.00K | $13.50 | $202.50K | BUY | 14.11% | 121.33K | Oct 24 | View |
| Oct 06, 2016 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $10.86 | -$1.09M | SELL-OPTIONS | 0.00% | 129.28K | Oct 04 | View |
| Sep 19, 2016 | Lutz Lingnau | DIRECTOR | 6.00K | $19.06 | -$171.54K | SELL-OPTIONS | 36.47% | 22.45K | Sep 15 | View |
| Sep 19, 2016 | CHRISTOPHER KUEBLER | DIRECTOR | 7.50K | $19.13 | -$143.47K | SELL-OPTIONS | 37.50% | 27.50K | Sep 15 - Sep 16 | View |
| Sep 19, 2016 | ROBERT CHESS | DIRECTOR | 3.00K | $19.21 | -$230.52K | SELL-OPTIONS | 1.15% | 263.62K | Sep 15 | View |
| Sep 02, 2016 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $11.24 | -$1.15M | SELL-OPTIONS | 0.00% | 129.30K | Sep 01 | View |
| Aug 17, 2016 | John Nicholson | SVP & CHIEF OPERATING OFFICER | -3.32K | $17.56 | -$58.25K | SELL | -2.65% | 121.98K | Aug 16 | View |
| Aug 17, 2016 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | -3.97K | $17.56 | -$69.73K | SELL | -8.26% | 44.09K | Aug 16 | View |
| Aug 17, 2016 | HOWARD ROBIN | PRESIDENT & CEO | -11.82K | $17.56 | -$207.51K | SELL | -8.38% | 129.28K | Aug 16 | View |
| Aug 17, 2016 | Gil M Labrucherie | SVP & CHIEF FINANCIAL OFFICER | -3.31K | $17.56 | -$58.04K | SELL | -5.89% | 52.78K | Aug 16 | View |
| Aug 17, 2016 | Maninder Hora | SVP PHARMA DEV & MFG OPS | -3.31K | $17.56 | -$58.04K | SELL | -5.98% | 52.00K | Aug 16 | View |
| Aug 17, 2016 | Ivan Gergel | SVP & CHIEF MEDICAL OFFICER | -1.69K | $17.56 | -$29.59K | SELL | -5.81% | 27.33K | Aug 16 | View |
| Aug 17, 2016 | Stephen Doberstein | SVP & CHIEF SCIENTIFIC OFFICER | -1.34K | $17.56 | -$23.46K | SELL | -6.59% | 18.93K | Aug 16 | View |
| Aug 03, 2016 | ROBERT CHESS | DIRECTOR | 0.00 | $11.21 | -$60.55K | SELL-OPTIONS | 0.00% | 260.62K | Aug 01 | View |
| Jul 13, 2016 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | 0.00 | $9.87 | -$1.04M | SELL-OPTIONS | 0.00% | 6.81K | Jul 11 | View |
| Jul 05, 2016 | ROBERT CHESS | DIRECTOR | 0.00 | $9.63 | -$44.75K | SELL-OPTIONS | 0.00% | 260.62K | Jul 01 | View |
| Jun 03, 2016 | ROBERT CHESS | DIRECTOR | 0.00 | $10.32 | -$51.75K | SELL-OPTIONS | 0.00% | 260.62K | Jun 01 | View |
| May 18, 2016 | John Nicholson | SVP & CHIEF FINANCIAL OFFICER | 1.31K | $6.79 | -$11.62K | SELL-OPTIONS | 1.72% | 77.63K | May 16 - May 17 | View |
| May 18, 2016 | HOWARD ROBIN | PRESIDENT & CEO | 3.46K | $6.79 | -$29.47K | SELL-OPTIONS | 24.88% | 17.34K | May 16 - May 17 | View |
| May 18, 2016 | Stephen Doberstein | SVP & CHIEF SCIENTIFIC OFFICER | 536.00 | $6.79 | -$4.60K | SELL-OPTIONS | 110.52% | 1.02K | May 16 - May 17 | View |
| May 18, 2016 | Ivan Gergel | SVP & CHIEF MEDICAL OFFICER | 818.00 | $6.79 | -$5.87K | SELL-OPTIONS | 117.87% | 1.51K | May 16 - May 17 | View |
| May 18, 2016 | Maninder Hora | SVP PHARMA DEV & MFG OPS | 1.33K | $6.79 | -$11.34K | SELL-OPTIONS | 22.95% | 7.13K | May 16 - May 17 | View |
| May 18, 2016 | Gil M Labrucherie | SVP & GENERAL COUNSEL | 1.33K | $6.79 | -$11.35K | SELL-OPTIONS | 20.20% | 7.92K | May 16 - May 17 | View |
| May 18, 2016 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | 1.15K | $6.79 | -$9.83K | SELL-OPTIONS | 22.31% | 6.31K | May 16 - May 17 | View |
| Apr 27, 2016 | Lutz Lingnau | DIRECTOR | 0.00 | $12.32 | -$118.50K | SELL-OPTIONS | 0.00% | 16.45K | Apr 25 | View |
| Mar 11, 2016 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | 0.00 | $9.22 | -$77.10K | SELL-OPTIONS | 0.00% | 5.16K | Mar 09 | View |
| Feb 18, 2016 | Ivan Gergel | SVP & CHIEF MEDICAL OFFICER | 694.00 | $5.96 | -$6.63K | SELL-OPTIONS | ∞ | 694.00 | Feb 16 - Feb 17 | View |
| Feb 18, 2016 | John Nicholson | SVP & CHIEF FINANCIAL OFFICER | 1.20K | $5.96 | -$11.48K | SELL-OPTIONS | 1.60% | 76.32K | Feb 16 - Feb 17 | View |
| Feb 18, 2016 | HOWARD ROBIN | PRESIDENT & CEO | 3.48K | $5.96 | -$25.59K | SELL-OPTIONS | 33.41% | 13.89K | Feb 16 - Feb 17 | View |
| Feb 18, 2016 | Stephen Doberstein | SVP & CHIEF SCIENTIFIC OFFICER | 485.00 | $5.96 | -$4.65K | SELL-OPTIONS | ∞ | 485.00 | Feb 16 - Feb 17 | View |
| Feb 18, 2016 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | 1.16K | $5.96 | -$8.53K | SELL-OPTIONS | 28.98% | 5.16K | Feb 16 - Feb 17 | View |
| Feb 18, 2016 | Gil M Labrucherie | SVP & GENERAL COUNSEL | 1.34K | $5.96 | -$9.86K | SELL-OPTIONS | 25.50% | 6.59K | Feb 16 - Feb 17 | View |
| Feb 18, 2016 | Maninder Hora | SVP PHARMA DEV & MFG OPS | 1.20K | $5.96 | -$11.48K | SELL-OPTIONS | 26.15% | 5.80K | Feb 16 - Feb 17 | View |
| Feb 12, 2016 | Gil M Labrucherie | SVP & GENERAL COUNSEL | 0.00 | $8.97 | -$58.68K | SELL-OPTIONS | 0.00% | 5.25K | Feb 10 | View |
| Feb 12, 2016 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | 0.00 | $9.07 | -$72.60K | SELL-OPTIONS | 0.00% | 4.00K | Feb 10 | View |
| Feb 12, 2016 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $8.97 | -$335.33K | SELL-OPTIONS | 0.00% | 10.41K | Feb 10 | View |
| Jan 21, 2016 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | 0.00 | $10.38 | -$112.05K | SELL-OPTIONS | 0.00% | 4.00K | Jan 19 | View |
| Jan 21, 2016 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $10.29 | -$510.67K | SELL-OPTIONS | 0.00% | 10.41K | Jan 19 | View |
| Jan 21, 2016 | Lutz Lingnau | DIRECTOR | 0.00 | $9.83 | -$140.40K | SELL-OPTIONS | 0.00% | 16.45K | Jan 20 | View |
| Jan 21, 2016 | Gil M Labrucherie | SVP & GENERAL COUNSEL | 0.00 | $10.29 | -$89.37K | SELL-OPTIONS | 0.00% | 5.25K | Jan 19 | View |
| Dec 07, 2015 | Gil M Labrucherie | SVP & GENERAL COUNSEL | 0.00 | $11.36 | -$406.13K | SELL-OPTIONS | 0.00% | 5.25K | Dec 03 | View |
| Dec 07, 2015 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $11.29 | -$1.15M | SELL-OPTIONS | 0.00% | 10.41K | Dec 03 | View |
| Dec 07, 2015 | CHRISTOPHER KUEBLER | DIRECTOR | 0.00 | $10.48 | -$160.05K | SELL-OPTIONS | 0.00% | 20.00K | Dec 04 | View |
| Dec 07, 2015 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | 0.00 | $11.26 | -$138.30K | SELL-OPTIONS | 0.00% | 4.00K | Dec 03 | View |
| Nov 20, 2015 | SUSAN WANG | DIRECTOR | 0.00 | $11.33 | -$626.94K | SELL-OPTIONS | 0.00% | 20.00K | Nov 18 - Nov 20 | View |
| Nov 13, 2015 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $10.11 | -$852.17K | SELL-OPTIONS | 0.00% | 10.41K | Nov 11 | View |
| Nov 13, 2015 | Gil M Labrucherie | SVP & GENERAL COUNSEL | 0.00 | $10.18 | -$300.37K | SELL-OPTIONS | 0.00% | 4.75K | Nov 11 | View |
| Nov 13, 2015 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | 0.00 | $10.09 | -$103.05K | SELL-OPTIONS | 0.00% | 3.50K | Nov 11 | View |
| Oct 30, 2015 | Lutz Lingnau | DIRECTOR | 0.00 | $9.32 | -$66.88K | SELL-OPTIONS | 0.00% | 16.45K | Oct 28 | View |
| Oct 08, 2015 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $8.85 | -$535.92K | SELL-OPTIONS | 0.00% | 10.41K | Oct 06 | View |
| Oct 08, 2015 | Gil M Labrucherie | SVP & GENERAL COUNSEL | 0.00 | $8.92 | -$186.52K | SELL-OPTIONS | 0.00% | 4.75K | Oct 06 | View |
| Oct 08, 2015 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | 0.00 | $8.82 | -$65.10K | SELL-OPTIONS | 0.00% | 3.50K | Oct 06 | View |
| Sep 25, 2015 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | 0.00 | $9.84 | -$63.90K | SELL-OPTIONS | 0.00% | 3.50K | Sep 23 | View |
| Sep 25, 2015 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $9.87 | -$792.16K | SELL-OPTIONS | 0.00% | 10.41K | Sep 23 | View |
| Sep 25, 2015 | Gil M Labrucherie | SVP & GENERAL COUNSEL | 0.00 | $9.94 | -$278.76K | SELL-OPTIONS | 0.00% | 4.75K | Sep 23 | View |
| Aug 17, 2015 | Gilbert M. Labrucherie Jr. | SVP & GENERAL COUNSEL | 0.00 | $8.94 | -$130.33K | SELL-OPTIONS | 0.00% | 4.75K | Aug 13 | View |
| Aug 17, 2015 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $8.94 | -$228.08K | SELL-OPTIONS | 0.00% | 10.41K | Aug 13 | View |
| Aug 13, 2015 | John Nicholson | SVP & CHIEF FINANCIAL OFFICER | 65.12K | $9.32 | -$428.31K | SELL-OPTIONS | 651.16% | 75.12K | Aug 11 - Aug 12 | View |
| Jul 16, 2015 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $9.38 | -$280.00K | SELL-OPTIONS | 0.00% | 10.41K | Jul 14 | View |
| Jul 16, 2015 | Gilbert M. Labrucherie Jr., Attorney-in-Fact | SVP & GENERAL COUNSEL | 0.00 | $9.38 | -$160.00K | SELL-OPTIONS | 0.00% | 4.25K | Jul 14 | View |
| Jul 01, 2015 | SUSAN WANG | DIRECTOR | 0.00 | $9.84 | -$171.60K | SELL-OPTIONS | 0.00% | 20.00K | Jun 29 | View |
| Jun 23, 2015 | ROBERT CHESS | DIRECTOR | 0.00 | $10.31 | -$45.00K | SELL-OPTIONS | 0.00% | 260.62K | Jun 19 | View |
| Jun 17, 2015 | Lutz Lingnau | DIRECTOR | 0.00 | $8.90 | -$112.50K | SELL-OPTIONS | 0.00% | 16.45K | Jun 15 | View |
| Jan 15, 2015 | CHRISTOPHER KUEBLER | DIRECTOR | 0.00 | $12.41 | -$107.85K | SELL-OPTIONS | 0.00% | 20.00K | Jan 13 | View |
| Dec 31, 2014 | ROBERT CHESS | DIRECTOR | 0.00 | $15.29 | -$2.95K | SELL-OPTIONS | 0.00% | 260.62K | Dec 29 | View |
| Dec 24, 2014 | Jillian Thomsen | SVP & CHIEF ACCOUNTING OFFICER | 0.00 | $13.47 | -$20.90K | SELL-OPTIONS | 0.00% | 3.00K | Dec 22 | View |
| Dec 02, 2014 | Gil M Labrucherie | SVP & GENERAL COUNSEL | 0.00 | $10.83 | -$1.48M | SELL-OPTIONS | 0.00% | 4.25K | Nov 28 - Dec 01 | View |
| Dec 02, 2014 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $11.99 | -$3.51M | SELL-OPTIONS | 0.00% | 10.41K | Nov 28 - Dec 01 | View |
| Nov 26, 2014 | Gil M Labrucherie | SVP & GENERAL COUNSEL | 0.00 | $14.03 | -$21.21K | SELL-OPTIONS | 0.00% | 3.75K | Nov 24 | View |
| Nov 26, 2014 | HOWARD ROBIN | PRESIDENT & CEO | 0.00 | $14.88 | -$435.49K | SELL-OPTIONS | 0.00% | 10.41K | Nov 24 - Nov 25 | View |
| Nov 26, 2014 | Lutz Lingnau | DIRECTOR | 0.00 | $11.91 | -$93.15K | SELL-OPTIONS | 0.00% | 16.45K | Nov 24 | View |
| Nov 04, 2014 | Gil M Labrucherie | SVP & GENERAL COUNSEL | 0.00 | $12.58 | -$23.76K | SELL-OPTIONS | 0.00% | 3.75K | Nov 03 | View |
| Aug 08, 2013 | CHRISTOPHER KUEBLER | DIRECTOR | 0.00 | $11.91 | -$12.50K | SELL-OPTIONS | 0.00% | 20.00K | Aug 05 | View |
| Aug 07, 2013 | ROY WHITFIELD | DIRECTOR | 0.00 | $11.91 | -$12.50K | SELL-OPTIONS | 0.00% | 40.00K | Aug 05 | View |
| Oct 01, 2012 | CHRISTOPHER KUEBLER | DIRECTOR | 0.00 | $9.66 | -$25.00K | SELL-OPTIONS | 0.00% | 20.00K | Sep 27 | View |
| Sep 18, 2012 | DENNIS WINGER | DIRECTOR | 5.00K | $9.18 | $45.91K | BUY | 133.33% | 8.75K | Sep 14 | View |
| Jul 17, 2012 | ROBERT CHESS | DIRECTOR | 0.00 | $7.31 | -$57.12K | SELL-OPTIONS | 0.00% | 260.62K | Jul 13 | View |
| Mar 09, 2011 | ROBERT CHESS | DIRECTOR | 5.50K | $9.00 | -$40.50K | SELL-OPTIONS | 2.20% | 255.71K | Mar 07 - Mar 08 | View |
| May 12, 2010 | ROBERT CHESS | DIRECTOR | 0.00 | $10.03 | -$273.91K | SELL-OPTIONS | 0.00% | 255.12K | May 10 | View |
| May 14, 2009 | Gil M Labrucherie | SVP & GENERAL COUNSEL | 694.00 | $5.57 | -$2.20K | SELL-OPTIONS | 35.26% | 2.66K | May 12 | View |
| May 14, 2009 | Jillian Thomsen | VP & CHIEF ACCOUNTING OFFICER | 349.00 | $5.57 | -$1.12K | SELL-OPTIONS | 21.79% | 1.95K | May 12 | View |
| Nov 18, 2008 | Gil M Labrucherie | SVP & GENERAL COUNSEL | 721.00 | $4.37 | -$1.75K | SELL-OPTIONS | 57.82% | 1.97K | Nov 14 | View |
| Nov 18, 2008 | Jillian Thomsen | VP & CHIEF ACCOUNTING OFFICER | 364.00 | $4.37 | -$887.11 | SELL-OPTIONS | 29.40% | 1.60K | Nov 14 | View |
| Nov 18, 2008 | STUART JOHN PATTON | CHIEF SCIENTIFIC OFFICER | -3.26K | $4.37 | -$3.32K | SELL | -1.03% | 313.88K | Nov 14 | View |
| Mar 22, 2007 | ROBERT CHESS | CHAIRMAN THE BOARD | -17.70K | $12.23 | -$216.47K | SELL | -6.85% | 240.79K | Mar 22 | View |
| Mar 05, 2007 | HOWARD ROBIN | PRESIDENT & CEO | 10.00K | $11.27 | $112.70K | BUY | ∞ | 10.00K | Mar 05 | View |
| Mar 05, 2007 | LOUIS DRAPEAU | SR. VP FINANCE, CFO | 1.00K | $11.77 | $11.77K | BUY | 25.00% | 5.00K | Mar 05 | View |
| Jan 09, 2007 | ROBERT CHESS | CHAIRMAN, PRES. & CEO | -3.59K | $14.51 | -$52.12K | SELL | -1.69% | 208.62K | Jan 08 | View |
| Nov 07, 2006 | LOUIS DRAPEAU | SR. VP FINANCE, CFO | 1.00K | $14.65 | $14.65K | BUY | 33.33% | 4.00K | Nov 07 | View |
| Aug 10, 2006 | Louis Drapeau | SR. VP FINANCE, CFO | 1.00K | $16.35 | $16.35K | BUY | 50.00% | 3.00K | Aug 08 | View |
| May 18, 2006 | STUART JOHN PATTON | CHIEF SCIENTIFIC OFFICER | -1.63K | $20.21 | -$33.00K | SELL | -72.67% | 614.00 | May 15 | View |
| May 15, 2006 | Louis Drapeau | SR. VP FINANCE, CFO | 1.00K | $20.35 | $20.35K | BUY | 100.00% | 2.00K | May 15 | View |
| Mar 24, 2006 | AJIT GILL | PRESIDENT & CEO | -3.54K | $19.61 | -$69.53K | SELL | -3.87% | 87.99K | Mar 23 | View |
| Mar 13, 2006 | AJAY BANSAL | — | -5.17K | $19.92 | -$102.93K | SELL | -50.00% | 5.17K | Mar 10 | View |
| Mar 07, 2006 | ROBERT CHESS | EXECUTIVE CHAIRMAN | 3.35K | $9.90 | -$43.69K | GRANT | 1.69% | 201.67K | Mar 03 - Mar 07 | View |
| Mar 07, 2006 | STUART JOHN PATTON | CHIEF SCIENTIFIC OFFICER | 6.47K | $9.90 | -$76.29K | GRANT | 1.17% | 558.13K | Mar 03 - Mar 07 | View |
| Mar 03, 2006 | Louis Drapeau | SR. VP FINANCE, CFO | 1.00K | $20.08 | $20.08K | BUY | ∞ | 1.00K | Mar 03 | View |
| Jan 30, 2006 | AJIT GILL | PRESIDENT & CEO | -40.00K | $22.07 | -$882.92K | SELL | -32.91% | 81.54K | Jan 27 | View |
| Jan 30, 2006 | STUART JOHN PATTON | CHIEF SCIENTIFIC OFFICER | -20.00K | $22.00 | -$440.00K | SELL | -3.50% | 551.66K | Jan 27 | View |
| Jan 17, 2006 | STUART JOHN PATTON | CHIEF SCIENTIFIC OFFICER | -20.00K | $20.04 | -$400.72K | SELL | -3.75% | 513.66K | Jan 13 | View |
| Sep 12, 2005 | AJIT GILL | PRESIDENT & CEO | -30.00K | $21.17 | -$635.12K | SELL | -25.76% | 86.44K | Sep 09 | View |
| Sep 07, 2005 | AJIT GILL | PRESIDENT & CEO | -10.00K | $20.06 | -$200.61K | SELL | -7.91% | 116.44K | Sep 07 | View |
| Sep 07, 2005 | AJAY BANSAL | CFO, VP FINANCE & ADMIN | 0.00 | $12.69 | -$43.59K | SELL-OPTIONS | 0.00% | 0.00 | Sep 07 | View |
| May 17, 2005 | AJAY BANSAL | CFO, VP FINANCE & ADMIN | 0.00 | $16.41 | -$68.38K | GRANT | 0.00% | 0.00 | May 17 | View |
| May 10, 2005 | STUART JOHN PATTON | CHIEF SCIENTIFIC OFFICER | -1.75K | $14.47 | -$25.32K | SELL | -51.91% | 1.62K | May 10 | View |
| Mar 16, 2005 | STUART JOHN PATTON | CHIEF SCIENTIFIC OFFICER | 2.68K | $14.37 | -$21.37K | GRANT | 0.50% | 534.88K | Mar 14 | View |
| Jan 05, 2005 | AJAY BANSAL | CFO, VP FINANCE & ADMIN | 0.00 | $12.74 | -$102.42K | SELL-OPTIONS | 0.00% | 25.00K | Jan 03 | View |
| Dec 16, 2004 | STUART JOHN PATTON | CHIEF SCIENTIFIC OFFICER | -3.40K | $19.42 | -$66.03K | SELL | -60.60% | 2.21K | Dec 15 | View |
| Dec 01, 2004 | AJAY BANSAL | CFO, VP FINANCE & ADMIN | 3.00K | $12.71 | $38.14K | SELL-OPTIONS | 13.64% | 25.00K | Dec 01 | View |
| Mar 10, 2004 | ROBERT CHESS | EXECUTIVE CHAIRMAN | -23.78K | $18.19 | -$835.15K | SELL | -9.69% | 221.65K | Mar 08 | View |
| Mar 09, 2004 | ROBERT CHESS | EXECUTIVE CHAIRMAN | -54.93K | $15.36 | -$1.79M | SELL | -18.29% | 245.44K | Mar 05 | View |
| Mar 09, 2004 | AJIT GILL | PRESIDENT & CEO | -21.80K | $24.06 | -$524.51K | SELL | -20.50% | 84.56K | Mar 05 | View |
| Mar 08, 2004 | MILTON HARRIS | PRESIDENT NEKTAR AL | -100.00K | $21.73 | -$2.17M | SELL | -11.85% | 743.90K | Mar 04 | View |
| Mar 08, 2004 | AJIT GILL | PRESIDENT & CEO | 50.00K | $10.99 | -$1.10M | GRANT | 785.92% | 56.36K | Mar 04 | View |
| Mar 08, 2004 | ROBERT CHESS | EXECUTIVE CHAIRMAN | -18.67K | $13.10 | -$1.85M | SELL | -5.85% | 300.37K | Mar 04 | View |
| Mar 08, 2004 | STUART JOHN PATTON | CHIEF SCIENTIFIC OFFICER | -20.00K | $22.18 | -$443.52K | SELL | -3.79% | 507.31K | Mar 04 | View |
| Mar 08, 2004 | AJAY BANSAL | CFO, VP FINANCE & ADMIN | 0.00 | $13.49 | -$50.55K | SELL-OPTIONS | 0.00% | 25.00K | Mar 04 | View |
| Mar 03, 2004 | MILTON HARRIS | PRESIDENT NEKTAR AL | -35.96K | $19.70 | -$708.45K | SELL | -4.33% | 793.90K | Mar 02 | View |
| Feb 23, 2004 | ROBERT CHESS | EXECUTIVE CHAIRMAN | -1.89K | $12.48 | -$85.22K | SELL | -0.59% | 319.03K | Feb 19 | View |
| Feb 20, 2004 | MILTON HARRIS | PRESIDENT NEKTAR AL | -89.96K | $19.73 | -$1.77M | SELL | -9.98% | 811.88K | Feb 19 | View |
| Feb 20, 2004 | MILTON HARRIS | PRESIDENT NEKTAR AL | -31.74K | $19.80 | -$628.57K | SELL | -3.57% | 856.87K | Feb 18 | View |
| Feb 12, 2004 | ROBERT CHESS | EXECUTIVE CHAIRMAN | -23.01K | $12.27 | -$1.15M | SELL | -6.69% | 320.92K | Feb 10 | View |
| Feb 12, 2004 | STUART JOHN PATTON | CHIEF SCIENTIFIC OFFICER | -20.00K | $20.00 | -$400.00K | SELL | -3.65% | 527.31K | Feb 10 | View |
| Feb 12, 2004 | MILTON HARRIS | PRESIDENT NEKTAR AL | -80.00K | $19.77 | -$1.58M | SELL | -8.40% | 872.74K | Feb 10 | View |
| Jan 14, 2004 | STUART JOHN PATTON | CHIEF SCIENTIFIC OFFICER | -20.00K | $18.19 | -$363.73K | SELL | -3.53% | 547.31K | Jan 13 | View |
| Jan 12, 2004 | AJIT GILL | CEO & PRESIDENT | -25.00K | $16.09 | -$402.18K | SELL | -25.77% | 72.01K | Jan 08 | View |
| Jan 12, 2004 | MILTON HARRIS | PRESIDENT OF NEKTAR AL | -10.62K | $16.94 | -$179.91K | SELL | -1.15% | 912.74K | Jan 09 | View |
| Jan 09, 2004 | MILTON HARRIS | PRESIDENT OF NEKTAR AL | -32.79K | $16.12 | -$528.45K | SELL | -3.34% | 950.14K | Jan 08 | View |
| Jan 09, 2004 | MILTON HARRIS | PRESIDENT OF NEKTAR AL | -37.13K | $16.08 | -$597.10K | SELL | -4.01% | 889.82K | Jan 08 | View |
| Jan 09, 2004 | MILTON HARRIS | PRESIDENT OF NEKTAR AL | -26.78K | $16.28 | -$436.13K | SELL | -2.82% | 923.36K | Jan 08 | View |
| Jan 09, 2004 | MILTON HARRIS | PRESIDENT OF NEKTAR AL | -1.59K | $16.00 | -$25.52K | SELL | -0.16% | 973.36K | Jan 07 | View |
| Jan 09, 2004 | MILTON HARRIS | PRESIDENT OF NEKTAR AL | -18.97K | $15.62 | -$296.37K | SELL | -1.91% | 974.95K | Jan 07 | View |
| Jan 09, 2004 | MILTON HARRIS | PRESIDENT OF NEKTAR AL | -29.69K | $14.97 | -$444.58K | SELL | -2.90% | 993.93K | Jan 07 | View |
| Jan 09, 2004 | MILTON HARRIS | PRESIDENT OF NEKTAR AL | -19.64K | $15.65 | -$307.44K | SELL | -2.07% | 927.20K | Jan 07 | View |
| Jan 09, 2004 | MILTON HARRIS | PRESIDENT OF NEKTAR AL | -30.10K | $14.97 | -$450.80K | SELL | -3.08% | 946.84K | Jan 07 | View |
| Jan 08, 2004 | MILTON HARRIS | PRESIDENT OF NEKTAR AL | -10.45K | $15.26 | -$159.34K | SELL | -1.01% | 1.02M | Jan 06 | View |
| Jan 08, 2004 | MILTON HARRIS | PRESIDENT OF NEKTAR AL | -39.55K | $14.79 | -$585.19K | SELL | -3.69% | 1.03M | Jan 06 | View |
| Jan 08, 2004 | MILTON HARRIS | PRESIDENT OF NEKTAR AL | -10.45K | $15.26 | -$159.36K | SELL | -1.06% | 976.95K | Jan 06 | View |
| Jan 08, 2004 | MILTON HARRIS | PRESIDENT OF NEKTAR AL | -39.55K | $14.79 | -$585.17K | SELL | -3.85% | 987.39K | Jan 06 | View |
| Jan 07, 2004 | MILTON HARRIS | PRESIDENT OF NEKTAR AL | -3.30K | $14.38 | -$47.45K | SELL | -0.31% | 1.07M | Jan 05 | View |
| Jan 07, 2004 | MILTON HARRIS | PRESIDENT OF NEKTAR AL | -48.15K | $14.18 | -$682.91K | SELL | -4.28% | 1.08M | Jan 05 | View |
| Jan 07, 2004 | MILTON HARRIS | PRESIDENT OF NEKTAR AL | -48.55K | $14.18 | -$688.52K | SELL | -4.51% | 1.03M | Jan 05 | View |
| Jan 06, 2004 | MILTON HARRIS | PRESIDENT OF NEKTAR AL | -50.00K | $14.14 | -$707.10K | SELL | -4.26% | 1.12M | Jan 02 | View |
| Jan 06, 2004 | MILTON HARRIS | PRESIDENT OF NEKTAR AL | -50.00K | $14.14 | -$707.10K | SELL | -4.44% | 1.08M | Jan 02 | View |
| Jan 02, 2004 | MILTON HARRIS | PRESIDENT NEKTAR AL | -7.30K | $14.14 | -$103.33K | SELL | -0.62% | 1.17M | Dec 31 | View |
| Jan 02, 2004 | MILTON HARRIS | PRESIDENT NEKTAR AL | -100.00K | $14.10 | -$1.41M | SELL | -7.83% | 1.18M | Dec 30 | View |
| Oct 17, 2003 | ROBERT CHESS | EXECUTIVE CHAIRMAN | 0.00 | $9.78 | -$29.23K | SELL-OPTIONS | 0.00% | 343.93K | Oct 15 | View |
| Oct 17, 2003 | MILTON HARRIS | PRESIDENT NEKTAR AL | -50.00K | $15.00 | -$750.00K | SELL | -3.92% | 1.23M | Oct 15 | View |
| Oct 16, 2003 | ROBERT CHESS | EXECUTIVE CHAIRMAN | 0.00 | $9.78 | -$29.23K | SELL-OPTIONS | 0.00% | 343.93K | Oct 14 | View |
| Oct 16, 2003 | MILTON HARRIS | PRESIDENT NEKTAR AL | -3.80K | $15.00 | -$57.00K | SELL | -0.30% | 1.25M | Oct 14 | View |
| Oct 14, 2003 | ROBERT CHESS | EXECUTIVE CHAIRMAN | -21.00K | $9.57 | -$845.04K | SELL | -5.75% | 343.93K | Oct 13 | View |
| Oct 14, 2003 | MILTON HARRIS | PRESIDENT NEKTAR AL | -100.00K | $15.00 | -$1.50M | SELL | -7.39% | 1.25M | Oct 13 - Dec 13 | View |
FAQ
Q
Is insider trading legal?
A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q
What are some examples of market manipulation?
A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
NKTR Insider Trading News
People Also Watch
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved